LUCY JOSEPH: Open Payments
NPI 1720697188 · HOWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,894 in 107 payments from 26 companies in 2025. Trend: 2023 $501 · 2024 $1,938 · 2025 $2,894
Food & beverage: $1,551Long term medical supply or device loan: $881Education: $462
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $985 |
| Daiichi Sankyo Inc. | 18 | $368 |
| E.R. Squibb & Sons, L.L.C. | 17 | $280 |
| Gilead Sciences, Inc. | 5 | $145 |
| Astellas Pharma US Inc | 4 | $141 |
| AstraZeneca Pharmaceuticals LP | 8 | $139 |
| SEAGEN INC. | 1 | $95 |
| TAIHO ONCOLOGY, INC. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $80 |
| Janssen Biotech, Inc. | 4 | $69 |
Products named: KISQALI, Enhertu, OPDIVO, Trodelvy, LONSURF, KEYTRUDA, Lenvima, Fabhalta.
Industry payments across NJ — which companies pay providers there.
